Christopher R. Loose Frequency Therapeutics, Inc. (FREQ) insider trading activity

Christopher R. Loose is Chief Scientific Officer of Frequency Therapeutics, Inc.. Currently has a direct ownership of 183,650 shares of FREQ, which is worth approximately $0. The most recent transaction as insider was on Jul 28, 2023, when has been sold 1,344 shares (Common Stock) at a price of $0.46 per share, resulting in proceeds of $618. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 184K

0% 3M change

192.52% 12M change

Total Value Held $0

Christopher R. Loose Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 28 2023	SELL Open market or private sale	$618 $0.46 p/Share	1,344 Reduced 0.73%	183,650 Common Stock
Jul 27 2023	SELL Open market or private sale	$727 $0.53 p/Share	1,373 Reduced 0.74%	184,994 Common Stock
Jul 26 2023	SELL Open market or private sale	$677 $0.51 p/Share	1,329 Reduced 0.71%	186,367 Common Stock
Jul 25 2023	SELL Open market or private sale	$695 $0.5 p/Share	1,390 Reduced 0.74%	187,696 Common Stock
Jul 24 2023	SELL Open market or private sale	$776 $0.54 p/Share	1,438 Reduced 0.75%	189,086 Common Stock
Jul 21 2023	SELL Open market or private sale	$813 $0.61 p/Share	1,333 Reduced 0.69%	190,524 Common Stock
Jul 20 2023	SELL Open market or private sale	$871 $0.64 p/Share	1,361 Reduced 0.7%	191,857 Common Stock

Jul 19 2023	SELL Open market or private sale	$867 $0.65 p/Share	1,335 Reduced 0.69%	193,218 Common Stock
Jul 18 2023	SELL Open market or private sale	$831 $0.56 p/Share	1,484 Reduced 0.76%	194,553 Common Stock
Jul 17 2023	SELL Open market or private sale	$948 $0.67 p/Share	1,415 Reduced 0.72%	196,037 Common Stock
Jul 14 2023	SELL Open market or private sale	$534 $0.59 p/Share	906 Reduced 0.46%	197,452 Common Stock
Jul 13 2023	SELL Open market or private sale	$518 $0.39 p/Share	1,329 Reduced 0.67%	198,358 Common Stock
Jul 12 2023	SELL Open market or private sale	$520 $0.39 p/Share	1,335 Reduced 0.66%	199,687 Common Stock
Jul 11 2023	SELL Open market or private sale	$504 $0.37 p/Share	1,363 Reduced 0.67%	201,022 Common Stock
Jul 10 2023	SELL Open market or private sale	$482 $0.37 p/Share	1,304 Reduced 1.94%	66,023 Common Stock
Jul 10 2023	BUY Exercise of conversion of derivative security	-	4,546 Added 6.05%	70,569 Common Stock
Jul 07 2023	SELL Open market or private sale	$470 $0.36 p/Share	1,306 Reduced 2.04%	62,781 Common Stock
Jul 07 2023	BUY Exercise of conversion of derivative security	-	4,546 Added 6.33%	67,327 Common Stock
Jul 06 2023	SELL Open market or private sale	$470 $0.34 p/Share	1,384 Reduced 2.34%	57,758 Common Stock
Jul 06 2023	BUY Exercise of conversion of derivative security	-	4,546 Added 7.14%	59,142 Common Stock
Jul 05 2023	BUY Exercise of conversion of derivative security	-	4,546 Added 7.69%	54,596 Common Stock
Jul 06 2022	SELL Open market or private sale	$6,755 $1.53 p/Share	4,415 Reduced 8.11%	50,050 Common Stock
Jul 05 2022	BUY Exercise of conversion of derivative security	-	15,000 Added 21.59%	54,465 Common Stock
Feb 22 2022	SELL Open market or private sale	$3,774 $3.53 p/Share	1,069 Reduced 2.98%	34,827 Common Stock
Feb 18 2022	SELL Open market or private sale	$3,769 $3.87 p/Share	974 Reduced 2.64%	35,896 Common Stock

CRL

Christopher R. Loose

Chief Scientific Officer

Lexington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FREQ shares.

Notify only if

Value

Insider Trading

Get notified when an Frequency Therapeutics, Inc. insider buys or sells FREQ shares.

Notify only if

Operation

Value

Type

News

Receive news related to Frequency Therapeutics, Inc.

Track Activities on FREQ

Account